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Executive Summary  
 
 
mothers2mothers (m2m) is a peer support program that aims to provide education and psychosocial 
support to HIV-positive pregnant women and new mothers, help women access existing health care 
services to prevent mother-to-child transmission of HIV (PMTCT), and follow up with mothers and 
babies to ensure they receive appropriate medical care after delivery. While there has been much interest 
in innovative psychosocial support programs that complement PMTCT clinical services, only a few such 
programs exist, and there is very little data about their effectiveness. Although m2m is a well known 
program with anecdotal accounts of successfully supporting HIV-positive women, the program had yet to 
undergo an external evaluation. The Horizons Program of Population Council, in collaboration with 
Health Systems Trust, completed the first evaluation of m2m as part of its introduction in KwaZulu-Natal 
Province, South Africa.  
 
 
Study Design and Methods  
 
The researchers used a pre-post, quasi-experimental study design to assess program effectiveness. There 
were three evaluation sites in the Pietermaritzburg area of KwaZulu-Natal. These sites drew women from 
urban and peri-urban settings. The eligibility criteria for the study included being between the ages of 18 
and 49 years, knowing one’s HIV status, and either 6–9 months pregnant or 12 weeks or less postpartum. 
Two cross-sectional surveys were conducted. At baseline data collection in 2005 before m2m was 
introduced, 183 HIV-positive pregnant women and 178 HIV-positive postpartum women were 
interviewed using a structured questionnaire. At follow up data collection in 2006, one year after m2m 
was introduced, 345 HIV-positive pregnant women and 350 HIV-positive postpartum women were 
interviewed using the same questionnaire but with additional questions about program exposure and 
interaction. The sample size at follow up was larger in order to examine potential differences between 
those who participated in the program and those who did not participate. Program participation was 
defined as two or more contacts with m2m.  
 
Outcomes for the study included knowledge about mother-to-child transmission (MTCT) and its 
prevention, disclosure of HIV status to another person, Nevirapine receipt and uptake, infant feeding 
intentions and practice, family planning intentions and practice, referral and follow up for care, and 
psychosocial well-being. The study assessed whether there were better outcomes for program participants 
versus non-participants at the follow-up data collection, and examined potential changes between the two 
rounds of data collection—before the introduction of the m2m program and after the program was in 
place for one year. Bivariate and multivariate analyses were conducted. 
 
 
Key Findings  
 
The program achieved substantial coverage of both pregnant and postpartum women, with almost 60 
percent of women reporting that a mentor mother talked with them at least once while the women were 
pregnant or during their last pregnancy. Nearly half of all pregnant and postpartum women interviewed 
reported two or more interactions with a mentor mother.  
 
The sociodemographic characteristics of participants (women who had two or more contacts with the 




MTCT knowledge, overall respondents knew more basic information about how and when MTCT occurs 
than how to prevent it. Comparing the two groups, m2m participants had greater MTCT knowledge than 
non-participants, but most differences were not statistically significant. 
 
There were high rates of disclosure in the study population. Among postpartum women, m2m 
participants were significantly more likely to have disclosed to someone than non-participants (97 percent 
vs. 85 percent; p < 0.01), and to have done so prior to delivery. The person HIV-positive women, 
regardless of program exposure, disclosed most often to was their partner or husband.  
 
There was no difference in Nevirapine receipt by program exposure for pregnant women. But m2m 
program participants interviewed postpartum were more likely to report receipt and ingestion of 
Nevirapine, and receipt of the infant dose than non-participants, with about 9 out of 10 participants 
reporting as such. 
 
Formula feeding was the most common method of infant feeding mentioned, although neither the facility 
nor the program distributed formula. Pregnant and postpartum program participants were more likely to 
report intending or actually giving infant formula exclusively than their counterparts who had no exposure 
to the program.  
 
The vast majority (70 percent) of postpartum program participants (4–12 weeks after delivery) reported 
using contraception, with injection mentioned as the most common method. They were more likely to use 
contraception than non-participants.  
 
Program participants interviewed postpartum reported significantly higher rates of having undergone CD4 
testing during their last pregnancy (79 percent vs. 57 percent; p < 0.01) and knowing their CD4 count 
after testing (88 percent vs. 72 percent; p < 0.01) than non-participants.  
 
With respect to psychosocial well-being, pregnant participants were significantly more likely to report 
feeling they could do things to help themselves, cope with taking care of the baby, and live positively in 
comparison to non-participants. Postpartum participants reported feeling less alone in the world, 
overwhelmed by problems, and hopeless about the future compared to non-participants.  
 
The multivariate analysis controlled for age, existence of partner, education, employment, number of live 
births, number of antenatal care visits, and site. With these controls, program participation continued to be 
positively and significantly related to key PMTCT knowledge and behaviors, or there was a positive 
association that was not statistically significant. 
 
The data were also analyzed to assess whether the changes associated with program participation among 
postpartum women occurred between baseline and follow up data collection. Most findings were in the 
same direction, suggesting that the program contributed to positive changes at the site level after one year 





m2m plays an important role in providing a continuum of care for HIV-positive women and infants. 
Compared to non-participants, m2m participants had greater psychosocial well-being, greater use of 
PMTCT services, and better PMTCT outcomes. Postpartum participants had more positive changes than 




pregnant participants, suggesting that with more contacts and time with the program, there is greater 
impact. Lastly, m2m keeps women linked to health facilities, which is especially important after delivery 









The medical recommendations for the prevention of mother-to-child transmission (PMTCT) of HIV made 
by PMTCT programs are often difficult for women to implement because of community norms, values, 
and beliefs. For example, taking medication during pregnancy and using a breast milk substitute or 
exclusively breastfeeding and then early weaning are not normative practices for women. Many women 
are uncertain of the effect of these recommendations on their pregnancy and infant. Moreover, women 
may face stigma and other social costs if they follow providers’ PMTCT recommendations.  
 
Another barrier that interferes with the prevention of vertical transmission is that health providers are 
often overextended. HIV services have been added to existing responsibilities even as the number of 
nurses has declined in most African health facilities. In numerous settings, there are not enough nurses 
and midwives to give needed information and support to patients because of high rates of migration, and 
in high HIV prevalence settings, many providers themselves may suffer from AIDS-related illnesses.  
 
PMTCT programs have also found it difficult to follow up with women after delivery to address infant 
feeding, infant health, family planning, and women’s health. In many countries, once women deliver, 
most do not return to the antenatal care (ANC) or maternal child health (MCH) clinics where they 
received PMTCT services. This lack of participation in PMTCT-related programs during the postpartum 
period contributes to pediatric HIV infections. However, this can be reduced by improving the follow-up 
of HIV-positive mothers and their infants and fostering their utilization of health services.  
 
The mothers2mothers (m2m) program was created to respond to these PMTCT challenges. Recognizing 
that women need psychosocial support upon learning that they are HIV-positive, m2m provides peer 
support not only to help women accept their HIV status, but, together with information and education, to 
help women adhere to PMTCT recommendations. The program aims to supplement existing health 
services so that HIV-positive women and their infants receive comprehensive care and are able to access 
the full range of services available to them, as well as successfully carry out recommended practices.  
 
While anecdotal information suggested that m2m filled an important gap, the program had not been 
formally evaluated to determine whether it improved HIV-positive women’s psychosocial well-being, and 
to assess its added value in increasing the uptake of PMTCT services and in improving PMTCT 
knowledge and behaviors. In response, the Horizons Program, in collaboration with Health Systems 








Description of the Intervention 
 
m2m is a community-based education and mentoring program for HIV-positive pregnant women and new 
mothers. m2m trains and employs new mothers, who have themselves benefited from services, to become 
"mentor mothers." These mentors form a team of facility-based, grassroots caregivers and educators of 
HIV-positive mothers and are an integral part of clinical PMTCT care. m2m works to achieve the 
following goals:  
 
• Reduce the number of babies born with HIV.  
• Empower pregnant women and new mothers living with HIV to improve their health and the health of 
their babies.  
• Fight the stigma associated with HIV, and encourage and support disclosure.  
 
m2m is based on the concept that peer support is an optimal model for effective education and social 
empowerment, and that mothers themselves are the best vehicle to provide support to other mothers. 
Through education and community-based outreach activities, the program helps women learn to advocate 
for their own health and the health of their families; it also works to destigmatize HIV/AIDS within 
communities. Finally, the program provides employment and professional development for local women 





m2m employs experienced health care professionals as program managers to oversee local programs 
based in individual healthcare facilities. Each site is headed by a full-time site coordinator—usually a 
mentor mother who has come through the program. Site coordinators are responsible for supervising the 
delivery of care provided by mentor mothers.  
 
Mentor mothers participate in two weeks of training that covers basic medical knowledge about HIV 
infection and antiretroviral therapy (ART), behaviors that help prevent mother-to-child transmission, safer 
feeding options for infants, counseling methods that can help women to disclose their status, strategies for 
negotiating safer sexual practices, and nutritional guidelines for women living with HIV. Mentor mothers 
and site coordinators also help clients negotiate the healthcare system by giving them information about 





The m2m service model exists in partnership with provincial, district, and municipal initiatives to support 
the delivery of ANC, HIV testing and counseling, and treatment services. The program is designed to 
serve women throughout the entire PMTCT process—from the beginning of pregnancy through the first 
year of motherhood. m2m sites, including the sites where this evaluation was conducted, adhere to a 
common operating structure, linking and integrating closely with a clinic-based PMTCT program and also 
reaching into the community to work with women, their partners, and their family members both during 








Site coordinators and mentor mothers conduct daily outreach activities on days when there are clinic 
hours for ANC and/or MCH services in order to inform pregnant and newly delivered women coming to 
the health facility about the program. The general health talks are conducted in waiting rooms and cover 
information on m2m services, including the hours of operation, location of a designated m2m space 
within the clinic, schedule of support groups, and details about other activities offered by the program. 
These talks are generally a woman’s first exposure to m2m, although at some sites referral to m2m is part 
of the first ANC visit for all HIV-positive pregnant women. 
 
 
Counseling and support groups 
 
Mentor mothers and site coordinators provide one-on-one counseling for women in an m2m-designated 
space in the health facility on a daily basis. Mentor mothers also make daily visits to the labor and 
delivery wards to speak with expecting mothers who may be inpatients or newly delivered mothers who 
are awaiting discharge. m2m also conducts regular support group meetings within the clinic and provides 
nutritious lunches to the women who visit the site. Individual counseling and support group sessions 
address the PMTCT and self-care topics covered in the comprehensive two week training that mentor 





Mentor mothers and site coordinators also visit women at home to assist with disclosure, support women 
in their choice of an exclusive infant feeding method1, promote safer sex and family planning, and 




m2m in the Study Sites  
 
m2m provides services in 17 sites in KwaZulu-Natal. HIV prevalence among pregnant women in 
KwaZulu-Natal, South Africa’s most populous province, is approximately 39 percent, the highest in the 
country (Department of Health, Republic of South Africa 2005). PMTCT services are offered through 
government-supported health facilities, which provide rapid HIV testing at the first prenatal care visit, 
Nevirapine for women in labor and Nevirapine syrup for infants after delivery, and infant testing for HIV 
at six weeks of age using HIV DNA PCR tests. 
 
Among the 17 m2m sites in KwaZulu-Natal, ten are in Pietermaritzburg, the province’s second largest 
city (estimated population: 350,000–500,000). The Pietermaritzburg sites are funded by a President’s 
Emergency Plan for AIDS Relief (PEPFAR) grant administered through the Elizabeth Glaser Pediatric 
AIDS Foundation (EGPAF). Three of these sites were selected for the evaluation: Edendale Hospital, a 
tertiary care hospital in central Pietermaritzburg; Imbalenhle Community Health Center (CHC), a multi-
                                                     
1In accordance with the WHO recommendations, m2m does not advocate either breast or formula feeding but rather educates 
women about the importance of selecting an exclusive feeding method, ideally during pregnancy, and then supports women’s 
decisions and helps them maintain their choice post-delivery.  
 




disciplinary health center in a peri-urban area close to Edendale Hospital; and Mpophomeni Clinic, a 
primary care clinic close to Pietermaritzburg. Each facility provides basic ANC and delivery services, 
though few deliveries are done at Mpophomeni Clinic—most women who arrive in labor are referred to 
Imbalenhle CHC and Edendale Hospital. 
 
Each facility provides general adult and pediatric medical services with an emphasis on primary care and 
preventive services at Mpophomeni; primary and secondary care, preventive, and curative services at 
Imbalenhle CHC; and tertiary care curative services at Edendale Hospital. Comprehensive HIV care, 
including ART programs, was introduced at each facility during the course of the evaluation.  
 
m2m has dedicated program space in Edendale Hospital where women can meet both individually and in 
groups. Space constraints have been a challenge at Imbalenhle CHC, where individual meetings take 
place in ad hoc spaces and group sessions are held in an X-ray file room. At Mpophomeni Clinic m2m 
first used an open courtyard which was suitable during good weather but lacked privacy; the nurses’ tea 
room, which was available except during the nurses’ tea time, and the postpartum ward beds, which were 
rarely occupied by patients, were also used. Toward the end of the evaluation a parkhome (mobile home) 
was erected for PMTCT services and m2m was given dedicated space for its program. 
 
At each facility m2m provides service five days per week to women attending ANC, to women in the 
postpartum wards, and when mothers return to the facility after delivery for self care and baby care. 
During the evaluation, there were six m2m program staff at Edendale and Imbalenhle, and five at 
Mpophomeni.  
 
Site coordinators and mentor mothers are present throughout the clinic day engaging women in individual 
and group sessions. A hot or cold meal, prepared by the site coordinator and mentor mothers at each site, 
is served to all mothers attending m2m services each day. m2m staff are also available to go home with a 








Research Question and Study Design 
 
The central research question of the evaluation was, “Does m2m increase HIV-positive women’s 
utilization of key PMTCT services, and improve their psychosocial well-being and PMTCT knowledge 
and behaviors?” The research team used a quasi-experimental design to answer this question. Using a 
structured survey, the research team collected baseline data from a cross-section of pregnant and 
postpartum women attending ANC/MCH services prior to the introduction of the m2m program in the 
three sites (September–November 2005) and from a second cross-sectional sample of pregnant and 
postpartum women after the program was in place for approximately one year (August–October 2006) at 
Edendale Hospital, Imbalenhle CHC, and Mpophomeni Clinic.  
 
To determine the effects of the program, the investigators compared data from baseline to follow-up 
among pregnant and post-partum women and between participants and non-participants in the program at 
follow-up for the following indicators:  
 
• PMTCT knowledge  
• Disclosure of HIV status 
• Receipt and ingestion of Nevirapine 
• Infant feeding intentions and practices 
• Family planning intentions and practices 
• Referral and follow-up for care 
• Psychosocial well-being 
 
The study hypothesized that women who participated in the m2m program, and thus received additional 
psychosocial support from peers, would have higher levels of knowledge and psychosocial wellbeing, and 
higher rates of disclosure, family planning use, appropriate infant feeding practices, and follow up care.  
  
  
Eligibility, Recruitment, and Data Collection Procedures  
 
Women were eligible for the study if they were between the ages of 18 and 49 years (inclusive) and they 
knew their HIV status. To participate in the study, pregnant women had to be between 6 and 9 months 
gestation. For new mothers, the eligibility criteria were slightly different at baseline (1–12 weeks 
postpartum) than at follow up (4–12 weeks postpartum). Clinic providers identified women who might 
qualify for the evaluation, briefly introduced the study to them, and referred them to the interviewers, who 
provided more information about the study.  
 
Although the main focus of the study was on HIV-positive women since they were the intended 
beneficiaries of the m2m program, a small number of HIV-negative women were also interviewed so that 
the study would not compromise the confidentiality of women’s HIV status by only enrolling HIV-
positive women. Data from the HIV-negative women are reported separately. 




Study sample  
 
The sample size of HIV-positive women was determined to detect a 15 percentage point difference 
between baseline and follow-up at a 5 percent significance level for the following key indicators of 
program impact: exclusive breastfeeding at six weeks and disclosure of HIV results to partner. Because 
the study design also called for comparing program participants and non-participants, the follow-up 
sample size was doubled in order to have statistical power to make similar comparisons in key indicators.  
 
At baseline, 10 percent of the women approached were not eligible because they did not know their HIV 
status. The refusal rate among those who were eligible to participate was 6 percent. At follow-up, 1 
percent of the individuals approached were not eligible because of unknown HIV status. The refusal rate 
among those who were eligible to participate was 3 percent.  
 
Due to slight delays in obtaining the necessary approvals for conducting the research activities at the sites, 
and the need to start program activities, there was some overlap of baseline data collection with 
intervention activities. Therefore, a question about program exposure was included in the baseline 
questionnaire, and 18 HIV-positive pregnant and 46 HIV-positive postpartum women who reported 
interacting with the program were removed from the baseline sample. Table 1 summarizes the total 
number of HIV-positive pregnant and post-partum women interviewed at baseline and at follow-up that 
were used for analysis.  
 
 





HIV-positive pregnant women 183 345 
HIV-positive postpartum women 178 350 
 
 
Development of evaluation instruments and training of interviewers  
 
The principal investigators from the Horizons Program and Health Systems Trust jointly developed the 
evaluation protocol and instruments. Staff from m2m reviewed the protocol and instruments. 
  
Health Systems Trust translated the questionnaire into Zulu and back translated it into English. The 
questionnaire was pre-tested to ensure that the study population understood the questions and that 
culturally appropriate phrases were used.  
 
Health Systems Trust recruited university graduates with previous work experience to be interviewers. All 
of the interviewers were female because it was deemed culturally appropriate to have only women in the 
health facilities conducting the interviews with female respondents. The interviewers completed two 
weeks of training prior to each round of data collection. Staff from the Horizons Program and Health 
Systems Trust jointly conducted the interviewer training. The training covered the importance of 






Participants’ responses were captured electronically using Perseus MobileSurvey software operating on a 
Dell Azim x51 handheld computer. This programming allowed for all of the questionnaire’s skip patterns 
and range checks to execute automatically during the interview, which greatly facilitated the appropriate 
flow through the questionnaire and speedy recording of responses by the interviewers. If questions 
required any length of free text entry, it was entered using the onscreen keyboard. The use of handheld 
computers for recording the survey responses decreased interview time with respect to paper instruments 
and eliminated the need for data entry. On a daily basis, after the interviews were completed, the data 
manager uploaded the data to a desktop computer then converted the data to SPSS for quality control, 
management, analysis, and storage. Backup files were encrypted and emailed offsite nightly to the 
research team, who were the only ones who had access to the data.  
 
 
Ethical procedures  
 
The evaluation protocol was approved by the Population Council’s IRB, USAID, and the University of 
Stellenbosch in South Africa. The Horizons Program obtained ethical approval in the United States, while 
Health Systems Trust obtained in-country approval. The study’s interviewers were trained on the 
importance of following ethical guidelines, including maintaining confidentiality. Written informed 
consent was obtained from all women who were interviewed. Participants were compensated 40 Rand 
(approximately $6 US dollars) in recognition of costs such as travel, child care, and other expenses 
associated with participation in the study. Interviews were conducted at the clinics in a private space. 
Participants were not asked to give their names except to sign the written informed consent form. These 




Data analysis  
 
The study examined how PMTCT knowledge and behaviors, and uptake of services changed over time 
(baseline to follow-up) and differed based on whether or not women participated in m2m activities. The 
m2m program considered a minimum of two contacts between a mentor mother and an antenatal or 
postpartum client to be programmatically meaningful; therefore, study respondents were considered 
program participants if they spoke with a mentor mother two or more times. The definition of a contact 
was broad; a contact could occur either before or after delivery, and could involve participation in a one-
on-one interaction or a group session.  
 
At follow-up, 42 percent of the 345 pregnant women and 49 percent of the 350 postpartum women 
interviewed were considered program participants. For each of the key outcomes, the research team 
compared program participants to women who had no contact with the program. For clarity in presenting 
the study results and for understanding the potential impact of the program, data from women who had 
only one contact (16 percent of pregnant women and 9 percent of postpartum women) were removed from 
the analyses. 
 
SPSS (v12.0.2) and STATA (v9.2) were used process the data. Frequencies and means were used to 
describe the population and cross tabulations were used for bivariate analysis. As appropriate, the 
following statistical tests were conducted to compare differences between groups: chi-square, t test, 
fisher’s exact test, and two-sample test of proportions. After reviewing the bivariate results, multivariate 
analyses were conducted to explore the relationship between program participation and the following 




outcomes: disclosure of HIV status, Nevirapine intake by women, receipt of infant dose of Nevirapine, 
infant feeding practice, contraceptive use, and CD4 test taken during last pregnancy (see Appendix 1). 
   
The variables selected for inclusion in the multivariate model were determined by conducting a literature 
review of factors associated with uptake of PMTCT services as well as results of the analyses of the key 
significant bivariate relationships between program exposure and program outcomes. The multivariate 
model controlled for age, existence of partner2, education, employment, number of live births (proxy for a 
previous pregnancy), number of ANC visits, and study site. The same model was used for each of the 
outcomes.  
 
In addition to assessing differences between program participants and non-participants, the study explored 
whether changes occurred from baseline to follow-up. This included examining data regardless of 
program participation from the cross section at baseline and the cross section at follow up. These data can 
be interpreted as a diffusion effect to see whether the changes sought by the introduction of the m2m 
program are measurable at the site level. Such changes could occur because of temporal changes related 
to other HIV-related initiatives or activities in the study sites or m2m program impact at the site level.  
 
For these analyses (multivariate and baseline to follow-up), only the results from postpartum women are 
presented. By this time, women had already completed their pregnancy and had the opportunity to go 
through the various steps to reduce vertical transmission during pregnancy and also to begin carrying out 
recommended health practices after delivery. This analysis allows for the documentation of practice rather 
than intention.  
 
 
Sociodemographic Profile of Respondents 
 
The sociodemographic profile of pregnant and postpartum women interviewed at follow-up who had no 
contact with the program was very similar to those who had two or more contacts. Overall, more than half 
of the women interviewed had a partner or husband. The mean age was in the late twenties. On average, 
pregnant women were in their seventh month of gestation and had one child, while postpartum women 
were two months past delivery and had two children. Most women had at least some secondary schooling; 
more than half reported no income. The vast majority used electricity for cooking, and access to clean 
water was nearly universal. Pregnant women who participated in the m2m program were somewhat 
younger and better educated than those who did not participate (Table 2).  
 
Among HIV-positive postpartum women, the sociodemographic characteristics of those interviewed at 
baseline and those interviewed at follow-up were similar on some measures and different on others. At 
both rounds of data collection, the mean age was about 27, the mean number of living children was two, 
and women were, on average, in their second month post delivery. Access to clean water was nearly 
universal, with almost all women reporting access to a tap. The sociodemographic differences that were 
both statistically significant and programmatically important are as follows: women interviewed at 
follow-up had higher levels of education, were more likely to be employed, and a greater proportion had 




                                                     









(n = 143) 
Pregnant 
women:  
2 or more 
contacts 





(n = 147) 
Postpartum 
women: 
2 or more 
contacts 
(n = 173) 
Marital status      
    Single/never married 43% 45% 37%  45%  
    Partner/husband 56% 53% 62%  54%  
    Separated or widowed   1%    3%†   1%   1% 
Mean age 28.1    26.1** 26.8 27.6 
Mean number of living children    1.0   1.0   1.8   1.9 
Mean number of months gestation    7.6   7.6 N/A N/A 
Mean number of weeks postpartum  N/A N/A   8.1   8.6 
Education: at least some secondary  77%   87%* 83%  87% 
Unemployed 55%  64% 60%  57% 
Access to clean water: tap for 
individual house or several 
households 
97%  99% 99%  99% 
Fuel for cooking: electric 85% 88% 86% 90% 
 
* p < .05  
** p < .01 
†The total does not add up to 100 percent due to rounding. 
NA = Not applicable 
 
 









(n = 350) 
Mean age 26.8 27.2 
Mean number of living children   2.0  1.9 
Mean number of weeks postpartum    5.5§    8.3§ 
Education: at least some secondary  80%   87%* 
Unemployed 70%   58%* 
Access to clean water: tap for individual house or several 
households 
96%   99%* 
Fuel for cooking: electric 74%   88%** 
 
* p < .05  
** p < .01 
§The eligibility criteria were slightly different for postpartum women interviewed at baseline (1–12 weeks postpartum) compared to 
those interviewed at follow-up (4–12 weeks postpartum)  




The study took place within the context of a relatively strong health care infrastructure. Baseline findings 
revealed that most women had already established contact with ANC/MCH services. Overall, there was 
regular ANC attendance, nearly universal rates of delivery at a health facility, and very high levels of HIV 
testing among the study population. Most of the women interviewed at baseline were newly diagnosed as 
HIV-positive, having learned their status either during this pregnancy for pregnant women, or their last 











m2m achieved substantial coverage at the three evaluation sites with high rates of program 
participation by both pregnant and postpartum women.  
 
Awareness of the program was high among respondents from the three study sites. Two-thirds of HIV-
positive women interviewed (n = 695) at follow-up reported that they had heard about a program called 
“mothers2mothers.” Seven out of 10 women reported that they had met an individual wearing a 
“mothers2mothers” T-shirt.  
 
Beyond building program recognition, m2m staff made a substantial number of contacts among both 
pregnant and postpartum HIV-positive women. Among the 345 HIV-positive pregnant women who were 
interviewed at follow-up, 6 out of 10 women reported that a mentor mother had talked to them. For those 
who reported this type of contact, the median number of reported contacts was two (range 1–22)3. More 
than a third of all HIV-positive pregnant women interviewed indicated that they talked to a mentor mother 
one-on-one while nearly half participated in a group session held at the clinic (Figure 1).  
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For HIV-positive postpartum women (n = 350), 54 percent reported that a mentor mother spoke to them 
during their most recent pregnancy, and 39 percent reported that this occurred at least once after delivery. 
Among those who established contact with a mentor mother, the median number of contacts was four 
during pregnancy (range 1–10) and two after delivery (range 1–15). With respect to the type of 
interaction, 40 percent of all HIV-positive postpartum women interviewed at follow-up engaged in a one-
on-one discussion, and half participated in a group session either during pregnancy or after delivery 
(Figure 2).  
                                                     
3Since women interviewed were on average in their seventh month of pregnancy, there was potential for more interactions with 
the program to occur during women’s last trimester of pregnancy.  
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m2m participants had greater knowledge about mother-to-child transmission than non-
participants, but most differences were not significant.  
 
Overall, there was greater knowledge about MTCT and its prevention among pregnant and postpartum 
women who participated in the program. However, most of the differences between program participants 
and non-participants were not statistically significant. On the whole women had more information about 






Table 4   MTCT knowledge among HIV-positive pregnant and postpartum women:  









2 or more 
contacts 










2 or more 
contacts 
(n = 173) 
Percent 
Pregnant women who are HIV+ transmit 
HIV to their babies  
83  91* 79 86 
HIV+ mother can infect her baby with HIV 
during pregnancy  
55 66 57 65 
HIV+ mother can infect her baby with HIV 
during delivery  
80 86 77 83 
HIV+ mother can infect her baby with HIV 
during breastfeeding  
64  75* 72 82 
How can infection be prevented in babies 
of HIV+ women? Mentioned drugs at 
antenatal, delivery, or after delivery 
64 62 59 60 
How can infection be prevented in babies 
of HIV+ women? Mentioned only give 
formula or only give breast milk  
51 52 50 56 
 





Postpartum m2m participants were significantly more likely to have disclosed their status 
to someone than non-participants, and to have done so prior to delivery.  
 
The study examined disclosure of serostatus among respondents because disclosure may facilitate 
adherence to PMTCT recommendations, and because it is an explicit goal of m2m to encourage and 
support women to disclose to at least one person.  
 
Postpartum women who had two or more contacts with m2m were significantly more likely to have 
disclosed than non-participants (97 percent vs. 85 percent; p < .01). Furthermore, among those who 
disclosed, program participants were more likely to have disclosed prior to delivery than non-participants 
(91 percent vs. 81 percent; p < .05). Finally, program participants reported disclosure to more people than 
non-participants (median of 3 vs. 2).  
 
However, among pregnant women there were similarly high rates of disclosure between women who had 
two or more contacts with the program in comparison to those who had no contact (88 percent vs. 80 
percent). Among those who disclosed to someone, participants and non-participants reported having told 
a median of two people (range 1–25).  
 
Women were asked, “After you received your test results, were you afraid of disclosing your status?” 
Nearly 6 out of 10 pregnant and post-partum women (both program participants and non-participants) 




responded affirmatively. Despite the fear of telling someone about being diagnosed as HIV-positive, more 
than 8 out of 10 pregnant women disclosed their serostatus to someone.  
 
Logistic regression analysis was conducted to determine the degree of association between program 
exposure and disclosure. After having controlled for potential confounders, postpartum program 
participants were 4.4 times more likely to have disclosed than non-participants (adjusted odds ratio: 4.4; 
95 percent CI: 1.6–11.9; p < .05). These multivariate results and the nearly universal rate of disclosure 
among postpartum women who are m2m participants suggest that a central goal of the program is being 
met.  
  
The overall pattern of which individuals to whom HIV-positive women disclosed is broadly similar 
between program and non-program participants, with partner/husband the most frequently mentioned 
individual (Figure 3). Consistent with this finding is the fact that more than 8 out of 10 pregnant and 
postpartum women stated that they had ever discussed the importance of faithfulness with their 
partner/husband as well as the importance of condom use. 
 
 
Figure 3   Individuals to whom HIV-positive pregnant and postpartum women disclosed: 














Pregnant women:  0 contact (n = 114)
Pregnant women:  2 or more contacts (n = 128)
Postpartum women:  0 contact (n = 123)
Postpartum women: 2 or more contacts (n = 167)  
 
 
Receiving Ingestion of Nevirapine 
 
Postpartum program participants were more likely to report receipt and ingestion of 
Nevirapine, as well as receipt of the infant dose. 
 
Postpartum women were asked if they were taking ARVs for their own health. Approximately 25 percent 




non-participants. These data suggest that the study sites are successfully enrolling eligible women for 
treatment. Among those who were not on ARVs, program participants were significantly more likely to 
have received a prophylactic drug to prevent MTCT and to have ingested the drug in comparison to 
women who did not participate in the program. Finally, program participants were significantly more 
likely to report that they had received the infant dose within three days (Table 5).  
 
 
Table 5   Nevirapine receipt for postpartum women and infants: Non-participants vs. 
  program participants  
 Postpartum women:  
0 contact 
(n = 111) 
Percent  
Postpartum women:  
2 or more contacts 
(n = 125) 
Percent 
Provided with a drug to prevent MTCT 86* 95* 
Drug taken by woman   83**  93** 
 (n = 147) (n = 173) 




* p < .05  
** p < .01 
 
 
In the multivariate analysis, program participants were nearly two times more likely to have taken a 
prophylactic drug (adjusted odds ratio: 1.9; 95 percent CI: 0.7–5.1) and received the infant dose (adjusted 
odds ratio: 1.9; 95 percent CI: 1.0–3.7) than non-participants, although these differences were not 
statistically significant.  
 
With regard to pregnant women, nearly two-thirds reported that they had received Nevirapine, but there 
was no statistically significant difference between program participants and non-participants. However, 
among those who received it, program participants were significantly more likely to be able to state the 
correct name of the drug (Table 6).  
 
 
Table 6  Nevirapine receipt and knowledge among pregnant women: Non-participants vs.  
 program participants  
 Pregnant women:  
0 contact 
(n = 143) 
Percent 
Pregnant women:  
2 or more contacts 
(n = 146) 
Percent 
Provided with a drug to prevent MTCT 59 63 
 (n = 85) (n = 92) 
Woman able to state correct name of drug  88  97* 
 
* p < .05 
 
 






Postpartum program participants were more likely to report practicing an exclusive 
method of feeding, with most feeding their child infant formula without giving breast milk.  
 
The evaluation examined infant feeding intentions (two months post-delivery) among pregnant women 
and practice among postpartum women who were 4-12 weeks postpartum. The data were analyzed to 
explore rates of an exclusive method of feeding recommended by international guidelines (WHO 2006c). 
Program participants (both pregnant and postpartum) were significantly more likely to state that they were 
intending to give or actually had given only infant formula to their baby. Among pregnant women, the 
intention to breastfeed exclusively was significantly less among program participants than among non-
participants. However, postpartum m2m participants were significantly more likely to report practicing an 
exclusive method of feeding than non-participants (Table 7).  
 
 
Table 7  Exclusive method of infant feeding: Intentions among pregnant and practice 









2 or more 
contacts 










2 or more 
contacts 
(n = 173) 
Percent 
Infant formula but no breast milk 60   73* 61    78** 
Exclusive breastfeeding  27    17* 15  11 
Exclusive method of feeding (total of above) 87  90  76     89** 
 
* p < .05  
** p < .01 
 
 
In light of the bivariate results indicating that postpartum program participants were more likely to report 
infant formula but no breast milk, logistic regression analysis was conducted to determine the degree of 
association after controlling for potential confounders. The multivariate model demonstrated that 
postpartum program participants were 2.4 times more likely to report having given infant formula but no 
breast milk (2.4; 95 percent CI: 1.4–4.1; p < .05). 
 
These results of reported greater adherence to recommended feeding practices are supported by 
postpartum program participants being more likely to have decided on a feeding method before delivery 
than non-participants (87 percent vs. 71 percent, p < .01). Among those who decided on a feeding method 
before delivery, 9 out of 10 postpartum women (both program participants and non-participants) indicated 
that they were feeding their infant using the method they had previously selected, suggesting that in this 
study population almost all women are able to execute their plans if they make a decision prior to 
delivery. This may be facilitated by the context of low stigma around formula feeding in the study 
communities. Among postpartum women who were giving infant formula, women were asked, “Have you 
ever put your baby to your breast so that someone around you would not suspect you are HIV-positive?” 







The vast majority of postpartum program participants reported using contraception, and 
injection was the most commonly mentioned method.  
 
Because the prevention of unintended pregnancy among HIV-positive women is a key strategy to reduce 
vertical transmission (UNFPA 2004; WHO 2004), and since birth spacing is a public health 
recommendation for all women regardless of HIV status (WHO 2006a), the study explored family 
planning intention and practice.  
 
About 9 out of 10 pregnant women regardless of program participation reported intending to use family 
planning after the infant was born. Moreover, nearly 8 out of 10 pregnant women (no difference by 
program participation) intended to begin family planning within the first month after delivery versus a 
later time frame.  
 
Women who were 4–12 weeks postpartum were asked whether they were using contraception. A minority 
of women interviewed (23 percent of program participants and 18 percent of non-participants) had 
resumed sexual activity since the birth of the infant. In the bivariate analysis, postpartum program 
participants were significantly more likely to report using contraception than non-participants (70 percent 
vs. 58 percent, p < .05). The multivariate model also showed greater use of contraception among program 
participants, though this finding did not quite reach statistical significance (adjusted odds ratio: 1.6; 95 





Postpartum program participants reported substantially higher rates of having a CD4 test 
during their last pregnancy and knowing their CD4 count.  
 
The most recent WHO recommendations for PMTCT include the importance of eligible women accessing 
ARV treatment during pregnancy both for their own health as well as for a more effective means of 
preventing vertical transmission (WHO 2006b).  
 
For pregnant women, there was no difference between participants and non-participants with respect to 
CD4 testing and knowledge of their CD4 count among those who tested, with roughly two-thirds 
answering affirmatively to these questions (Table 8). It is understandable that there were no differences 
given that women were just beginning to participate in m2m activities and that the first type of support 
given by the program is focused on helping women to accept their HIV status, followed by information 
and support around adherence to the medical recommendations to decrease vertical transmission.  
 
Postpartum program participants had more exposure to the program, with a median of four contacts 
during pregnancy compared to two contacts reported by the sample of pregnant women. As shown in 
Table 8, there was a significant difference between postpartum program participants and non-participants 
regarding CD4 testing during their last pregnancy (79 percent vs. 57 percent, p < .01). Logistic regression 
analysis further supported the relationship between program exposure and CD4 testing, as postpartum 
program participants were 3.3 times more likely to have undergone CD4 testing during their last 
pregnancy compared to non-participants (adjusted odds ratio: 3.3; 95 percent CI 1.9–5.9; p < .01).  
 




Moreover, among those who had a CD4 test, bivariate results demonstrated that postpartum program 
participants were more likely to know their CD4 count (Table 8). These results suggest that m2m may be 
filling a gap by helping women to follow medical recommendations.  
 
 
Table 8  CD4 testing among pregnant and post-partum women: Non-participants vs. 









2 or more 
contacts 










2 or more 
contacts 
(n = 173) 
Percent 
CD4 test taken during pregnancy 66 69 57** 79** 
 (n = 95) (n = 101) (n = 83) (n = 136) 
Knew CD4 count among those who tested 62 67 72** 88** 
 
** p < .01 
 
 
Psychosocial Well-being  
 
Program participants report significantly greater psychosocial well-being than their 
counterparts on several measures.  
 
The study explored women’s psychosocial well-being by asking them to respond to a series of statements 
about how they were feeling in the last two weeks. Table 9 shows the percentage of women who reported 
the feeling most of the time or sometimes in the past two weeks versus once in a while or never. Pregnant 
women who participated in the program felt better than non-participants with respect to positive 
statements around agency. More than 9 out of 10 pregnant program participants felt that they could do 
things to help themselves, cope with taking care of their infants, and live positively. On the other hand 
fewer postpartum program participants reported having negative feelings compared to non-participants, 






Table 9  Psychosocial well-being: Non-participants vs. participants  
Had this feeling most of the time or 









2 or more 
contacts 










2 or more 
contacts 
(n = 173) 
Percent 
Felt alone in the world 36 40  49*  36* 
Felt overwhelmed by problems 61 62  67*  55* 
Felt hopeless about future 50 46  65*  53* 
Felt could do things to help oneself   80**    92** 91 89 
Felt could cope with taking care of baby  85*  93* 89 90 
Felt could live positively    80**    93** 87 87 
 
* p < .05 
** p < .01 
 
 
Changes from Baseline to Follow-up 
 
There were also positive changes among postpartum women from baseline to follow-up on 
some measures. 
 
Table 10 summarizes and compares the findings among postpartum respondents by program participation 
and from baseline to follow-up. Most findings were in the same direction, including knowledge, 
disclosure, receipt of infant dose of Nevirapine, exclusive use of infant formula, CD4 testing, and 
women’s knowledge of their CD4 count among those who tested.  
 
But there were a few measures where the changes were not consistent by program participation and over 
time. For example, while program participants were significantly more likely to be using contraception, 
this finding did not hold when analyzing the responses from baseline to follow-up. This is not surprising 
because family planning programs have been in place for a long time in South Africa and have generally 
not been an emphasis of traditional PMTCT services. 
 
Another notable difference was that while program participants reported having less negative feelings 
about their own lives compared to non-participants, there was no change in these measures of 
psychosocial well-being between the two rounds of data collection. Given that only program participants 
received psychosocial support, changes were not expected in the entire study population.  
 









Table 10 Summary of results for postpartum women by program participation and 
  baseline to follow-up 
  Non-participants  
(n = 147) vs. 
Program participants  
(n = 173)  
Baseline  
(n = 178) vs. 
Follow up  
(n = 350)  
Knowledge about MTCT and its prevention 0 0 
Disclosed to at least one person  + + 
Nevirapine ingestion + Not available 
Infant dose receipt + + 
Infant feeding practice: 
    Formula, no breast milk 
    Exclusive breast milk  









Using family planning + 0 
Referral and follow up for care 
    CD4 tested during pregnancy 
    Women knew count among those tested 










    Felt alone in the world 
    Felt overwhelmed by problems 
    Felt hopeless about future 
    Felt could do things to help oneself 
    Felt could cope with taking care of baby 
















Key: +  statistically significant difference in expected direction 
 0  no statistically significant difference 
 -  statistically significant difference not in expected direction  
 
 
After reviewing the bivariate results with regard to changes over time, logistic regression analysis was 
carried out to ascertain if the relationships held within the multivariate model, particularly because there 
were some differences in the sociodemographic profiles between the baseline and follow-up samples. The 
multivariate model included the following variables: age, education, employment, number of live births, 
number of antenatal care visits, and site. Key outcomes such as disclosure, giving infant formula but no 
breast milk, receipt of infant dose of Nevirapine, and CD4 count tested during pregnancy held within the 
multivariate model, demonstrating a significant difference between baseline and follow-up after 
controlling for these variables.  
 
While the implementation of the m2m program was a very important intervention at the site level, as in 
all real world scenarios, there may be additional possible factors that contributed to the changes among 
respondents from baseline to follow-up. In general there was greater emphasis on ARVs at the study sites 
during the course of the evaluation. For example, Edendale Hospital benefited from technical and 
financial assistance provided by the Elizabeth Glaser Pediatric AIDS Foundation, which included for 





Conclusions and Recommendations 
 
 
The findings suggest that m2m plays an important role in providing a continuum of care for HIV-positive 
women and their infants. The program strives to keep women linked to health facilities, which is 
especially important after delivery since that is an identified weakness of traditional PMTCT services, 
where there are no established systems to follow up women and their infants. This evaluation found that 
there was an association between participation in the program and greater psychosocial well-being, 
increased uptake of PMTCT services, and more positive PMTCT behaviors, particularly among 
postpartum women. The fact that a greater number of positive outcomes were found within postpartum 
women is understandable given that they had more contacts with m2m staff than pregnant women, and 
also had more time to come to terms with being HIV-positive and take steps to protect their health as well 
as the health of their infants. This suggests that there is a dose effect and more contacts and time with the 
program may lead to greater impact. 
 
The findings of significant differences on several important variables between postpartum program 
participants and non-participants are strengthened by the accompanying improvements among post-
partum women between baseline and follow-up. These results suggest that m2m may also be contributing 
to changes at the site level.  
 
With respect to MTCT knowledge, program participants were not more likely to have greater knowledge 
than non-participants, and there are still important information gaps among respondents. Given that HIV-
positive women should be fully informed about MTCT and its prevention, and that this knowledge may 
motivate women to adhere more closely to medical recommendations, m2m should do more to ensure 
that program participants receive and retain information.  
 
The study found high disclosure rates at baseline; nonetheless program participants reported even higher 
rates of disclosure than non-participants. The vast majority of HIV-positive women disclosed to someone, 
and shared their status most often with their partner/husband. The disclosure rates from this study are 
higher than those reported from a synthesis of studies, which found that women testing in ANC as part of 
nascent PMTCT programs reported lower rates of disclosure than at free-standing VCT centers (Medley 
et al. 2004). This suggests that disclosure is now more common than what had been reported during the 
beginning stages of PMTCT programs and that the way individuals have responded to the epidemic has 
changed over time. The findings from this study likely reflect that in the facilities—and likely in the study 
communities—counseling and testing for HIV has become routine and normalized in ANC.  
 
The finding that postpartum program participants disclosed to more individuals than non-participants 
underlies the importance of considering disclosure of HIV status as an ongoing process (Varga, Sherman, 
and Jones 2006). This suggests that with more time and greater comfort with one’s HIV status, which is 
an important psychosocial support provided by m2m, women may be increasingly open about their HIV 
status. Increased rates of disclosure may in turn facilitate other positive behaviors around HIV and AIDS, 
such as adherence to ARV prophylaxis and treatment, and an exclusive method of infant feeding. 
 
In two important areas, receipt and ingestion of short course antiretroviral prophylaxis and exclusive 
infant feeding practice, postpartum program participants were more likely to adhere to PMTCT program 
recommendations than non-participants. These findings suggest that the program contributes to helping 
women to reduce vertical transmission through ensuring receipt of necessary drugs and maintaining an 
exclusive method of infant feeding.  




With respect to infant feeding, services at these sites can build on their success by directing attention 
toward the women who are practicing mixed feeding and the challenges these women face in maintaining 
an exclusive feeding method. Infant feeding counseling and postpartum support are important in helping 
women make appropriate feeding choices and adhere to these choices (Bland et al. 2007; Doherty et al. 
2006). The continuation of one-on-one and group sessions provided by the program up to six weeks post-
delivery is an optimal opportunity to provide such support.  
 
Continued interaction with women after delivery also enables the program to support HIV-positive 
women to adopt strategies to prevent unintended pregnancy when considerations of family planning are 
more relevant. This is in marked contrast to traditional PMTCT services which typically only interact 
with women while they are pregnant. Family planning information and services are often overlooked in 
traditional PMTCT programs as most programs are not able to provide a quality continuum of care for 
HIV-positive women after delivery nor provide adequate services to help HIV-positive women access 
family planning should they desire it. (Baek and Rutenberg 2005; Rutenberg and Baek 2005).  
 
The greater rates of referral and follow-up around CD4 testing found among program participants and 
improvements between baseline and follow up data collection are encouraging and demonstrate that 
necessary protocol changes at sites can be implemented within a short time. Services at these sites can 
build on this success and work toward ensuring that all HIV-positive women are tested for their CD4 
count during pregnancy, and those who are eligible begin ARVs while pregnant.  
 
The significant differences between program participants and non-participants regarding psychosocial 
well-being suggest that there is a role for programs such as m2m in helping women accept what it means 
to be HIV-positive for themselves and their families.  
 
In terms of limitations, the study used non-randomized samples. The number of sites included in the 
evaluation and the sample sizes were small, in major part due to cost considerations of conducting 
research activities in South Africa. Despite positive associations between program participation and key 
indicators, given the cross-sectional nature of the study, cause and effect cannot be determined. Moreover, 
this evaluation relied on self-reported data and there were no biological markers such as PCR testing. So 
while the findings presented in this evaluation are proxy measures for reducing vertical transmission, it 
would be important to directly assess whether participation in m2m contributes to lower HIV 
transmission rates among infants born to HIV-positive mothers. In addition, the background rates of 
antenatal care attendance, health facility delivery, HIV testing, and disclosure were high prior to the 
introduction of m2m. It will be important to replicate and expand this study to a sub-Saharan African 
setting where the infrastructure for ANC/MCH is fundamentally weaker with lower rates of ANC 
attendance and delivery, and where there are deeper levels of poverty and underdevelopment.  
 
Despite the limitations, the study has a number of strengths. It is the first external evaluation that provides 
quantitative evidence about the role of the well-known m2m program in complementing PMTCT 
services. The study examined what contribution peer support can make toward improving psychosocial 
well-being among HIV-positive women, uptake of PMTCT services, and PMTCT knowledge and 
behaviors. The prospective design took into account temporal changes and reduced recall bias. Data were 
analyzed in two major ways: both pre-and post-intervention as well as a dose response in terms of 
program participation. Moreover, the evaluation was conducted in a real world setting rather than a 
controlled clinical environment, which results in data that are more useful in terms of application for 
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Multivariate Regression Methods 
 
 
To explore associations between knowledge and behaviors measured at pre- and post-intervention and 
between women who were and were not exposed to the m2m program with respect to the study’s main 
outcomes, researchers selected and included a limited number of key variables to control for non-program 
factors that may have affected program outcomes. They were determined by conducting a literature 
review of factors associated with uptake of PMTCT services as well as examining the results of the 
analyses of the key significant bivariate relationships between program exposure and program outcomes. 
Logistic regression was chosen as it can describe the relationship of exposure to an intervention with a 
dichotomous outcome while controlling for a number of independent covariates. Logistic regression is 
based on the logistic function, which ranges between zero and one. It models the probability that the 
exposure leads to the outcome, one being always associated while zero deems no association. 
Furthermore, it allows for a variety of formats to be used when quantifying exposure and covariates such 
as ordinal, nominal, and continuous constructs as well as combinations of these variables to be included 
in a model. The multivariate model controlled for age, existence of partner, education, employment, 
number of live births (proxy for a previous pregnancy), number of ANC visits, and study site. The same 
model was used for each of the outcomes. Log likelihood chi-square and Hosmer and Lemeshow’s 
goodness of fit tests confirmed that this one logistic model adequately fit all outcomes of interest. 
Muticollinearity was assessed by computing variance inflation factors (an indicator of how much of the 
inflation of the standard error could be caused by collinearity) for each variable included in the model; 
none reported a value above our threshold value of 10. 
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